Meletios A. Dimopoulos, MD, discussed the phase III Boston study examining a new combination therapy to treat patients with multiple myeloma who have received 1 to 3 prior therapies.
Jesús F. San Miguel, Vânia Hungria, Sung‐Soo Yoon, W Wiktor-Jędrzejczak, Ashraf Elghandour, Noppadol Siritanaratkul, Meletios A Dimopoulos, Paolo Corradini, Thanyaphong Na Nakorn, Tatiana Shelekhova, Andreas Günther, Kwee Yong, Robert Schlossman, Monika M Wroclawska-Swacha, Hans‐Jochen Weber, Priscille Bourquelot, Jian Hou, Hermann Einsele, Jae Hoon Lee, Philippe Moreau, Sagar Lonial, Paul G. Richardson
Maria Teresa Petrucci, Pilar Giraldo, Paolo Corradini, Adriana Teixeira, Meletios A Dimopoulos, Igor Wolfgang Blau, Johannes Drach, Ralf Angermund, Nathalie Allietta, Esther Broer, Vivien Mitchell, Joan Bladé
María‐Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella, Holger W. Auner, Michèle Cavo, Meletios A Dimopoulos, Martina Bianco, G Merlo, Charles la Porte, Philippe Moreau
Jesús F. San Miguel, Philippe Moreau, Sung‐Soo Yoon, Meletios A Dimopoulos, Vânia Hungria, W Wiktor-Jędrzejczak, Ashraf El Ghandour, Paolo Corradini, Andreas Günther, Meral Beksaç, Kwee Yong, Jae Hoon Lee, Sagar Lonial, Jian Hou, Hermann Einsele, Monika M Wroclawska-Swacha, Hans‐Jochen Weber, Priscille Bourquelot, Paul G. Richardson
Discussion(0)
No comments yet. Be the first to comment.